Conditions: Pulmonary Disease, Chronic Obstructive
Keywords: COPD Multicenter GSK233705B double-blind Chronic Obstructive Pulmonary Disease (COPD) randomized
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 576
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the efficacy and safety of GSK233705B compared with placebo in subjects with COPD.

Detailed description:

Arms:
arm 1: GSK233705 12.5mcg arm 2: GSK233705 25mcg arm 3: GSK233705 50mcg arm 4: GSK233705 100mcg arm 5: GSK233705 200mcg arm 6: Placebo

Interventions: intervention 1: GSK233705 12.5mcg intervention 2: GSK233705 25mcg intervention 3: GSK233705 50mcg intervention 4: GSK233705 100mcg intervention 5: GSK233705 200mcg intervention 6: Placebo
Intervention descriptions: intervention 1: Once daily via dry powder inhaler intervention 2: once daily via dry powder inhaler intervention 3: Once daily via dry powder inhaler intervention 4: Once daily via dry powder inhaler intervention 5: Once daily via dry powder inhaler intervention 6: Once daily via dry powder imhaler

Protocol document: